Pulmonary non-tuberculous mycobacterial infections: current state and future management

Kai Ling Chin1, Maria E Sarmiento2, Nadine Alvarez-Cabrera3

  • 1Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah (UMS), Kota Kinabalu, Sabah, Malaysia. chinkl@ums.edu.my.

Insights

Pulmonary non-tuberculous mycobacterial infections (PNTM) are increasing globally, especially in developed nations. Addressing these neglected infections requires improved diagnostics, therapies, and vaccines beyond current tuberculosis efforts.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Rising incidence of pulmonary non-tuberculous mycobacterial infections (PNTM) contrasts with declining tuberculosis (TB) rates, particularly in developed countries.
  • Prevalence of PNTM in low-resource settings is largely unknown due to a lack of suitable diagnostic methods.
  • Environmental exposure and host-pathogen interactions are key predisposing factors for PNTM.

Purpose of the Study:

  • To review the current epidemiology and predisposing factors of PNTM.
  • To discuss the challenges and ongoing efforts in controlling PNTM.
  • To highlight the need for expanded research and development for neglected mycobacterial diseases.

Main Methods:

  • Literature review of current trends in PNTM and TB incidence.
  • Analysis of factors contributing to PNTM emergence, including environmental and socio-economic aspects.
  • Discussion of diagnostic, therapeutic, and vaccine development efforts for mycobacterial diseases.

Main Results:

  • Increasing global incidence of PNTM, with a concurrent decrease in TB.
  • Identification of environmental proximity and population changes as drivers of PNTM.
  • Significant gaps in PNTM diagnostics and control strategies, especially in developing regions.

Conclusions:

  • PNTM represents a growing global health concern, often overlooked compared to TB.
  • Development and environmental changes contribute to the rise of PNTM.
  • Urgent need for enhanced diagnostics, treatments, and vaccines for PNTM is emphasized.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
497
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
835
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
448
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
773
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.0K